| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
1 Department of Developmental and Medical Technology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan, 2 Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario M5G 1X5, Canada, 3 Department of Physiological and Metabolism, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan and 4 National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan
Correspondence should be addressed to H Suzuki; Email: hisuzuki{at}obihiro.ac.jp
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Recent studies have shown that it is possible to transfer the nucleus from an ES cell to the enucleated oocyte and achieve embryonic development under the control of the transferred nuclei. These findings suggest that the epigenetic state of donor nuclei is reprogrammed in the enucleated oocyte. However, many researchers have also shown that the majority of the pups obtained after the transfer of cloned embryos die soon after birth (Wakayama et al. 1999, Rideout et al. 2000, Amano et al. 2001, Eggan et al. 2001). This suggests that ES cells already had profound epigenetic modification during in vitro culture. Nevertheless, the nuclear-transferred embryos from these ES cells have at least the potential for early embryonic development. Recently, it has been shown that ES cell lines can be established from cloned blastocysts (ntES cell) with the ability to differentiate both in in vitro and in vivo conditions (Munsie et al. 2000, Wakayama et al. 2001).
The ES cells also are able to differentiate in vitro into several lineages. The simplest technique is the formation of an embryoid body (EB), which includes ectodermal, endodermal, and mesodermal lineages. In early studies, to estimate the potential of a newly established ES cell line, in vitro formation of EB was frequently performed by suspension culture (Robertson 1987). Moreover, it has been demonstrated that there is a relationship between the ability to differentiate into simple embryoid body (SEB) or cystic embryoid body (CEB) in vitro and the potential of germline transmission chimeric mice (Suzuki et al. 1997). Thus, the capacity for germline transmission of the ES cells can be estimated from the day of appearance of EBs in suspension culture.
In the present study, we examined whether low potential of ES cells with extensive passages (ES-ep) and hence with altered epigenetic status can be rescued by NT reprogramming.
| Materials and Methods |
|---|
|
|
|---|
In vitro differentiation
After the treatment of ES cells with trypsin (0.25%; Sigma), single cell suspensions (500 cells/20 µl drop) were cultured by the hanging drop method (Keller 1995) for 2 days in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum (Biowest Miami, FL, USA). The resulting ES cell aggregates were transferred into a bacteriological dish (10 cm; Nissui, Tokyo, Japan). These aggregates quickly delineated a layer of endoderm cells on their surface forming structures termed SEB. When suspension culture was continued, SEB formed CEB. These CEB were further cultured for several days to assess the spontaneous initiation of beating, suggesting that ES cells have differentiated to the mesodermal lineage. On the designated day for the appearance of SEB, CEB, or beating was determined by observing ten or more embryoid bodies per dish.
Tetraploid aggregation
ICR females (Clea, Tokyo, Japan) were superovulated by injection of equine chorionic gonadotropin (eCG) (5 IU, serotropin; Teikokuzouki, Tokyo, Japan) followed by human chorionic gonadotropin (hCG) 48 h later (5 IU, gonadotropin Teikokuzouki). After the administration of hCG, females were mated with same strain males and two-cell stage embryos were recovered from the oviduct by flushing with M2 medium (Fulton & Whittingham 1978). The recovered embryos were transferred to 0.3 M mannitol solution and aligned automatically by alternating current pulse in a chamber comprising two wire electrodes mounted 1 mm apart on a glass slide (Nepagene, Chiba, Japan). Then, two direct current pulses of 140 V/mm were given for 40 µs with a pulse generator (LF101; BEX, Tokyo, Japan). The fusion of two blastomeres occurred within 30 min and these fused embryos were considered to be tetraploids and cultured to the four-cell stage in a potassium simplex optimized medium (KSOM; Nagy et al. 1993) for 24 h at 37 °C in 5% CO2.
Nuclear transfer (NT)
The F1 mice (C57BL/6NxC3H/HeN) (Clea) were used as oocyte donors throughout. Unfertilized eggs were collected from superovulated females 13.515 h after the hCG injection and freed from the cumulus oophorous by hyaluronidase (300 Units; Sigma) treatment. They were then transferred into the M2 medium containing 5 µg/ml cytochalasin B (Sigma) and mechanically enucleated for use as recipient cytoplasm. A single ES cell, synchronized at metaphase by 3 µg/ml of nocodazole (Sigma) treatment for 3 h (Amano et al. 2001), was fused with an enucleated oocyte by electrofusion, in which the condition was 120 V/mm for 20 µs using an LF101 pulse generator manufactured by BEX. The oocytes fused with ES cells were then transferred into the KSOM medium supplemented with 5 µg/ml cytochalasin B for 1 h before activation. For activation, the fused oocytes were cultured in Ca2+-free KSOM supplemented with 10 mM Sr2+ (Sigma) for 5 h. The activated oocytes were cultured in vitro to the blastocyst stage (ntBlastocyst) and transferred to recipient mothers.
Establishment of ntES cell line
ntBlastocysts developed in vitro were treated with acidic Tyrodes solution (IS Japan, Japan) to remove Saitama the zona pellucida and then cultured in DMEM medium for ES cell culture (ES-DMEM) on mouse embryonic fibroblasts (Munsie et al. 2000). To establish ES cell lines, inner cell mass outgrowths were mechanically dissociated in the presence of 0.25% trypsin and then re-plated on mouse embryonic fibroblasts in ES-DMEM (ntES cell lines).
Comet assay
Each ES cell line (1x105 cells) was suspended in 50 µl of PBS and then transferred to 500 µl low-melting temperature agarose (Comet assay kit; Trevigen, Gaithersburg, MD, USA). Seventy-five microliters agarose including ES cells were placed on a slide glass. After 10 min, the ES cells were lysed by incubating the slides for 60 min in lysis buffer. The slides were then removed from the lysis solution, placed in alkaline solution for 60 min, and then transferred to an electrophoresis unit. The unit was filled with fresh TBE buffer to a level 0.25 cm above the slides, and electrophoresis was conducted for 10 min at 1 V/cm using an electrophoresis compact power supply. After electrophoresis, the slides were washed with 70% ethanol for 5 min. Each dried slide was stained with SYBR Green (Trevigen).
Recipient females and caesarean sections
The blastocysts were transferred to each uterine horn of pseudopregnant females on 2.5 days postcoitum (dpc). The recipient mothers were killed on 18.519.5 dpc, and the pups were quickly removed from the uterus. These pups were placed under a warming light and respiration was observed. Surviving pups were fostered to lactating ICR mothers.
Statistical analysis
The data were analyzed using the
2-method.
| Results |
|---|
|
|
|---|
|
|
ntES cell lines were established from blastocysts derived from NT of TT2-ep, YV1-ep, and YV1-lp ES cells. Of the 39, 26, and 37 ntblastocysts, eight cell lines were obtained in total. The efficiency of the isolation of ES cell lines ranged from 5 to 10% (Table 3
). The in vitro stability of the ntES cells was examined by chromosome and comet assay (Fig. 2
). The eight cell lines, which had a normal diploid chromosome constitution (n=40), were 5769% at passage 5 and the proportion was not different from the original ES cells. Moreover, no DNA damage was detected in any of the cell lines by comet assay.
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
|
When ntES cells derived from EC cells were tested for tumor or chimera formation, the resulting ntES cells displayed identical potential as their respective donor EC cells (Blelloch et al. 2004). In other words, genetic modification of EC cells was not completely reprogrammed in oocyte after NT and the characteristics of the EC cells were conveyed to the ntES cells. In the present study, the ntES cell lines derived from ES-ep cells exhibited low developmental potential to term after tetraploid complementation similar to the ability of the original ES cell lines (Table 4
). These results coincide with a previous report and show that it is difficult to rescue the developmental potential of ES cells, once lost by long-term culture, via NT, because the profound epigenetic modification was not precisely reprogrammed in oocyte.
In this study, we attempted to estimate the in vivo developmental potential of ES cell by in vitro differentiation ability, because accumulated epigenetic modifications in ES cell may influence the in vitro ability. The cell lines established did not have a remarkably different in vitro differentiation ability (Fig. 4
), when they were compared with original ES cell lines respectively. Suzuki et al.(1997) have shown that the in vitro differentiation ability of ES cells can be predicted from their germline contribution. This difference appears to depend on the number of ES cells at the initiation of EB formation. We have found that the ntES cell lines could be established from cloning of ES cell with ES-ep. However, profound epigenetic modifications accumulated by prolonged cultivation could not be reprogrammed via NT and ntES cells retained their low developmental potential in vivo.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Amano T, Kato Y & Tsunoda Y 2001 Full-term development of enucleated mouse oocytes fused with embryonic stem cells from different cell lines. Reproduction 121 729733.[Abstract]
Blelloch RH, Hochedlinger K, Yamada Y, Brennan C, Kim M, Mintz B, Chin L & Jaenisch R 2004 Nuclear cloning of embryonal carcinoma cells. PNAS 101 1398513990.
Dean W, Bowden L, Aitchison A, Klose J, Moore T, Meneses J, Reik W & Feil R 1998 Altered imprinted gene methylation and expression in completely ES cell derived mouse fetuses: association with aberrant phenotypes. Development 125 22732282.[Abstract]
Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout WM III, Yanagimachi R & Jaenisch R 2001 Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. PNAS 98 62096214.
Fulton BP & Whittingham DG 1978 Activation of mammalian oocytes by intracellular injection of calcium. Nature 273 149151.[CrossRef][Medline]
Hadjantonakis AK, Macmaster S & Nagy A 2002 Embryonic stem cells and mice expressing different gfp variants for multiple non-invasive reporter usage within a single animal. BMC Biotechnology 2 11.
Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM III, Biniszkiewicz D, Biniszkiewicz D, Yanagimachi R & Jaenisch R 2001 Epigenetic instability in ES cells and cloned mice. Science 293 9597.
Keller GM 1995 In vitro differentiation of embryonic stem cells. Current Opinion in Cell Biology 7 862869.[CrossRef][Web of Science][Medline]
Munsie MJ, Michalska AE, OBrien CM, Trounson AO, Pera MF & Mountford PS 2000 Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Current Biology 10 989992.[CrossRef][Web of Science][Medline]
Nagy A, Gócza E, Diaz EM, Prideaux VR, Iványi E, Markkula M & Rossant J 1990 Embryonic stem cells alone are able to support fetal development in the mouse. Development 110 815821.
Nagy A, Rossant J, Nagy R, Abramow-Newerly W & Roder J 1993 Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. PNAS 90 84248428.
Rideout WM III, Wakayama T, Wutz A, Eggan K, Jackson-Grusby L, Dausman J, Yanagimachi R & Jaenisch R 2000 Generation of mice from wile-type and targeted ES cells by nuclear cloning. Nature Genetics 24 109110.[CrossRef][Web of Science][Medline]
Robertson EJ 1987 Embryo-derived stem cell lines. In Teratocarcionomas and Embryonic Stem Cells: a Practical Approach, pp 71112. Oxford: IRL Press.
Suzuki H, Kamada N, Ueda O, Jishage K, Kurihara Y, Kurihara H, Terauchi Y, Azuma S, Kadowaki T, Kodama T, Yazaki Y & Toyoda Y 1997 Germ-line contribution of embryonic stem cells in chimeric mice: Influence of karyotype and in vitro differentiation ability. Experimental Animals 46 1723.
Tanaka M, Gertsenstein M, Rossant J & Nagy A 1997 Mash2 acts cell autonomously in mouse spongiotrophoblast development. Developmental Biology 190 5565.[CrossRef][Web of Science][Medline]
Ueda O, Jishage K, Kamada N, Uchida S & Suzuki H 1995 Production of mice entirely derived from embryonic stem (ES) cell with many passages by coculture of ES cells with cytochalasin B induced tetraploid embryos. Experimental Animals 44 205210.[CrossRef][Web of Science][Medline]
Wakayama T, Rodriguez I, Perry ACF, Yanagimachi R & Mombaerts P 1999 Mice cloned from embryonic stem cells. PNAS 96 1498414989.
Wakayama T, Tabar V, Rodriguez I, Perry ACF, Studer L & Mombaerts P 2001 Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Nature 292 740743.
Yagi T, Tokunaga T, Furuta Y, Nada S, Yoshida M, Tsukada T, Saga Y, Takeda N, Ikawa Y & Aizawa S 1993 A novel ES cell line, TT2, with high germline-differentiating potency. Analytical Biochemistry 214 7076.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
S. Snykers, J. De Kock, V. Rogiers, and T. Vanhaecke In Vitro Differentiation of Embryonic and Adult Stem Cells into Hepatocytes: State of the Art Stem Cells, March 1, 2009; 27(3): 577 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Condic and M. Rao Regulatory Issues for Personalized Pluripotent Cells Stem Cells, November 1, 2008; 26(11): 2753 - 2758. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hikichi, T. Kohda, S. Wakayama, F. Ishino, and T. Wakayama Nuclear Transfer Alters the DNA Methylation Status of Specific Genes in Fertilized and Parthenogenetically Activated Mouse Embryonic Stem Cells Stem Cells, March 1, 2008; 26(3): 783 - 788. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |